Insider · CIK 0001836816
Anders Ullman
Files at VRNA (Verona Pharma plc). First filing -, latest -.
In brief
Anders Ullman files SEC Form 4 as director at VRNA (Verona Pharma plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Anders Ullman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -358,856 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +72,000 | - | - | 72,000 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -72,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -72,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Share Options (Right to Buy)derivative | -200,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Share Options (Right to Buy)derivative | -96,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Share Options (Right to Buy)derivative | -240,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Share Options (Right to Buy)derivative | -64,000 | - | - | 0 | Oct 8, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +24,000 | $0.00 | $0 | 358,856 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Stock Unitsderivative | -24,000 | $0.00 | $0 | 72,000 | Aug 5, 2025 |
| Apr 25, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative | +96,000 | $0.00 | $0 | 96,000 | Apr 29, 2025 |
Questions about Anders Ullman
Answered from the filings on this page, as of the latest one.
Is Anders Ullman buying or selling?
Anders Ullman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Anders Ullman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anders Ullman has 0.
Where does Anders Ullman file Form 4?
Anders Ullman has filed Form 4 at VRNA (Verona Pharma plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.